Lab Information

W. Alton Russell (PhD)

Associate Investigator
Centre for Outcomes Research and Evaluation
Department of Epidemiology, Biostatistics and Occupational Health (McGill)

Research Profile

 Fundamental: 0%
 Clinical: 0%
 Epidemiology: 40%
 Evaluation: 60%
 This email address is being protected from spambots. You need JavaScript enabled to view it.
 http://mchi.mcgill.ca/decision-modeling-lab/

Keywords

Decision analysis • cost-effectiveness • simulation modeling • blood donation and transfusion • transfusion-transmitted infections

Research Interests

My research program aims to enable the efficient and effective use of finite healthcare resources by developing data-driven analyses that inform health policy and clinical decisions. I use methods from decision analysis, simulation, health economics, operations research, epidemiology, and data science. I have developed decision analytic models and data-driven analyses for multiple areas of health policy and clinical practice, including blood donation and transfusion, managing pediatric kidney disease, opioid use disorder and overdose, and gastroenterology.


Team Members

Name Position

Latest Publications

  1. Lim, J., Russell, W. A., El-Sheikh, M., Buckeridge, D. L. & Panagiotoglou, D. (2024). Correction: Economic evaluation of the effect of needle and syringe programs on skin, soft tissue, and vascular infections in people who inject drugs: a microsimulation modelling approach. Harm reduction journal, vol. 21, p. 164.
  2. Kuchukhidze, S., Walters, M. K., Panagiotoglou, D., Boily, M.-C., Diabaté, S., Russell, W. A., Stöckl, H., Sardinha, L., Mbofana, F., Wanyenze, R. K., Imai-Eaton, J. W. & Maheu-Giroux, M. (2024). The contribution of intimate partner violence to vertical HIV transmission: a modelling analysis of 46 African countries. The lancet. HIV, vol. 11, p. e542-e551.
  3. Stanley, J., Busch, M. P., Erikstrup, C., Galel, S. A., Holmberg, J. A., Lewin, A., O'Brien, S. F., Osiowy, C., Patidar, G., Russell, W. A., Spencer, B. R., Higgs, C. & Surveillance, Risk Assessment, Policy Sub‐group of the ISBT Transfusion Transmitted Infectious Diseases Working Party (2024). The International Society of Blood Transfusion (ISBT) Public Health Research Toolkit: A report from the Surveillance, Risk Assessment and Policy Sub-group of the ISBT Transfusion Transmitted Infectious Diseases Working Party. Vox sanguinis, vol. 119, p. 1122-1125.
  4. Lim, J., Russell, W. A., El-Sheikh, M., Buckeridge, D. L. & Panagiotoglou, D. (2024). Economic evaluation of the effect of needle and syringe programs on skin, soft tissue, and vascular infections in people who inject drugs: a microsimulation modelling approach. Harm reduction journal, vol. 21, p. 126.
  5. Jagirdar, H., Nwobi, N. H., Swanevelder, R., Cockeran, R., Bruhn, R., Kaidarova, Z., Bravo, M. D., van den Berg, K., Custer, B. S., Vassallo, R., Ding, Y., Panagiotoglou, D. & Russell, W. A. (2024). Blood donor return behavior in South Africa and the United States before and during the COVID-19 pandemic. Transfusion, vol. 64, p. 1492-1502.
  6. Yu, Y., Knight, M. J., Gibson, D., O'Brien, S. F., Buckeridge, D. L. & Russell, W. A. (2024). Temporal trends in disparities in COVID-19 seropositivity among Canadian blood donors. International journal of epidemiology, vol. 53.
  7. Li, N., Pham, T., Cheng, C., McElfresh, D. C., Metcalf, R. A., Russell, W. A., Birch, R., Yurkovich, J. T., Montemayor-Garcia, C., Lane, W. J., Tobian, A. A. R., Roubinian, N., Seheult, J. & Goel, R. (2023). Blood Demand Forecasting and Supply Management: An Analytical Assessment of Key Studies Utilizing Novel Computational Techniques. Transfusion medicine reviews, p. 150768.
  8. Vivas-Valencia, C., Dong, H., Stringfellow, E. J., Russell, W. A., Morgan, J. R., Tadrous, M. & Jalali, M. S. (2023). Factors Associated With Abrupt Discontinuation of Long-Term High-Dose Opioid Treatment. JAMA network open, vol. 6, p. e2341416.
  9. Claypool, A. L., DiGennaro, C., Russell, W. A., Yildirim, M. F., Zhang, A. F., Reid, Z., Stringfellow, E. J., Bearnot, B., Schackman, B. R., Humphreys, K. & Jalali, M. S. (2023). Cost-effectiveness of Increasing Buprenorphine Treatment Initiation, Duration, and Capacity Among Individuals Who Use Opioids. JAMA health forum, vol. 4, p. e231080.
  10. Dong, H., Stringfellow, E. J., Russell, W. A. & Jalali, M. S. (2023). Racial and Ethnic Disparities in Buprenorphine Treatment Duration in the US. JAMA psychiatry, vol. 80, p. 93-95.
More on PubMed